Firefly Neuroscience logo
Firefly Neuroscience
AIFF | NASDAQ
Chart Builder DCF Calculator
$0.89
-$0.05 (-4.81%)
At close: Nov 16, 2026, 4:00 PM ET
$0.87
-$0.02 (-2.24%)
After-hours: Nov 16, 2026, 5:35 PM ET

Firefly Neuroscience Company Profile

Company profile explained

Company Profile

Based in Toronto, Canada, Firefly Neuroscience, Inc. is a medical technology and artificial intelligence firm specializing in developing neuroscientific solutions. The company's primary goal is to enhance patient outcomes for individuals affected by mental illnesses and neurological disorders. Its flagship product, Brain Network Analytics, is a sophisticated software platform engineered to aid in the diagnosis and treatment of a diverse range of cognitive and psychiatric conditions. These conditions encompass, but are not limited to, depression, dementia, anxiety disorders, concussions, and attention-deficit/hyperactivity disorder. Firefly Neuroscience, Inc. caters to both pharmaceutical companies and medical practitioners.

Key Executives

Name Position
Greg Lipschitz Chief Executive Officer & Director
David DeCaprio President, Chief Operating Officer & Director
Gil Issachar Head of AI & Neuroscience
Jessica L. Paz Chief Accounting Officer
Paul Krzywicki Company Secretary

Latest SEC Filings

No SEC filings available
View All SEC Filings ➞
Firefly Neuroscience
Firefly Neuroscience logo
Country United States
IPO Date Nov 28, 2002
Industry Software - Application
Sector Technology
Employees 17
CEO Greg Lipschitz

Contact Details

1100 Military Road Kenmore, New York 14217 United States

Stock Details

Ticker Symbol AIFF
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0000803578
CUSIP Number 317970101
ISIN Number US3179701012
SIC Code 7372

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.